安旭生物
(688075)
| 流通市值：49.88亿 | | | 总市值：49.88亿 |
| 流通股本：1.27亿 | | | 总股本：1.27亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 233,627,337.96 | 441,570,489.4 | 467,922,697.94 | 190,499,987.45 |
| 交易性金融资产 | 1,364,949,013.69 | 1,407,632,027.4 | 1,536,027,972.61 | 1,835,950,243.83 |
| 应收票据及应收账款 | 190,784,202.06 | 283,512,930.5 | 203,690,596.91 | 253,603,712.29 |
| 其中：应收票据 | - | - | - | 108,000 |
| 应收账款 | 190,784,202.06 | 283,512,930.5 | 203,690,596.91 | 253,495,712.29 |
| 预付款项 | 21,884,588.55 | 27,003,838.75 | 20,146,454.23 | 47,962,649.55 |
| 其他应收款合计 | 10,012,412.38 | 6,569,943.12 | 7,995,596.61 | 13,102,767.43 |
| 存货 | 135,631,647.4 | 143,539,795.97 | 147,167,029.08 | 163,295,574.05 |
| 其他流动资产 | 2,815,505,400.72 | 2,538,075,456.09 | 2,387,032,579.9 | 2,334,528,836.5 |
| 流动资产合计 | 4,772,394,602.76 | 4,847,904,481.23 | 4,769,982,927.28 | 4,838,943,771.1 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 |
| 固定资产 | 606,738,947.24 | 614,098,691.12 | 624,938,284.16 | 631,795,241.75 |
| 在建工程 | 164,392,495.14 | 141,179,935.14 | 124,715,040.55 | 67,602,163.83 |
| 使用权资产 | 5,006,204.82 | 6,041,642.98 | 6,943,852.56 | 8,288,461.58 |
| 无形资产 | 43,505,358.99 | 44,639,687.24 | 45,776,759.73 | 45,511,971.41 |
| 长期待摊费用 | 15,382,206.17 | 16,740,250.95 | 18,076,978.1 | 17,106,889.71 |
| 递延所得税资产 | 162,758,217.94 | 160,084,062.25 | 161,112,486.85 | 166,449,252.24 |
| 其他非流动资产 | 10,692,905.19 | 8,306,405.7 | 11,764,566.04 | 15,304,723.15 |
| 非流动资产合计 | 1,014,476,335.49 | 997,090,675.38 | 999,327,967.99 | 958,058,703.67 |
| 资产总计 | 5,786,870,938.25 | 5,844,995,156.61 | 5,769,310,895.27 | 5,797,002,474.77 |
| 流动负债: | | | | |
| 短期借款 | - | - | 280,000 | 1,000,000 |
| 衍生金融负债 | - | - | - | 19,979,778.89 |
| 应付票据及应付账款 | 370,944,403.72 | 434,550,664.81 | 401,509,274.65 | 373,225,124.91 |
| 其中：应付票据 | 61,094,729.55 | 64,052,998.33 | 73,836,769.25 | 55,767,385.44 |
| 应付账款 | 309,849,674.17 | 370,497,666.48 | 327,672,505.4 | 317,457,739.47 |
| 预收款项 | 121,352.71 | - | - | - |
| 合同负债 | 19,318,637.98 | 22,620,620.08 | 17,832,868.21 | 23,003,188.22 |
| 应付职工薪酬 | 14,726,462.06 | 13,795,559.62 | 19,864,855.74 | 6,846,780.8 |
| 应交税费 | 12,794,054.46 | 7,397,722.87 | 18,394,720.23 | 5,571,658.17 |
| 其他应付款合计 | 121,240,267.1 | 19,580,759.85 | 13,167,337.5 | 102,956,824.87 |
| 应付股利 | 101,666,244 | - | - | 50,833,122 |
| 一年内到期的非流动负债 | 3,319,887.29 | 82,710.58 | 3,531,596.07 | 4,493,693.83 |
| 其他流动负债 | 257,838.35 | - | 734,362.16 | 2,791,828.81 |
| 流动负债合计 | 542,722,903.67 | 498,028,037.81 | 475,315,014.56 | 539,868,878.5 |
| 非流动负债: | | | | |
| 租赁负债 | 2,972,499.2 | 6,069,710.53 | 4,346,367.09 | 4,016,051.68 |
| 预计负债 | 3,596,125.7 | 27,825,850.02 | 8,104,370.02 | 30,610,482.68 |
| 递延收益 | 8,892,762.13 | 9,732,064.91 | 10,572,373.53 | 3,337,127.27 |
| 递延所得税负债 | 73,523,040 | 71,220,590.55 | 71,185,483.29 | 71,736,895.92 |
| 非流动负债平衡项目 | 0 | -0.01 | 0 | 0 |
| 非流动负债合计 | 88,984,427.03 | 114,848,216 | 94,208,593.93 | 109,700,557.55 |
| 负债合计 | 631,707,330.7 | 612,876,253.81 | 569,523,608.49 | 649,569,436.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 127,082,805 | 127,082,805 | 127,082,805 | 127,082,805 |
| 资本公积 | 1,050,333,724.27 | 1,050,333,724.27 | 1,050,333,724.27 | 1,050,333,724.27 |
| 其他综合收益 | 9,229,631.84 | 9,475,976.9 | 11,371,779.31 | 15,506,208.25 |
| 盈余公积 | 62,069,454.51 | 62,069,454.51 | 62,069,454.51 | 48,584,214.59 |
| 未分配利润 | 3,910,381,072.28 | 3,986,771,044.27 | 3,952,741,425.5 | 3,909,715,059.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0.01 |
| 归属于母公司股东权益合计 | 5,159,096,687.9 | 5,235,733,004.95 | 5,203,599,188.59 | 5,151,222,011.67 |
| 少数股东权益 | -3,933,080.35 | -3,614,102.15 | -3,811,901.81 | -3,788,972.94 |
| 股东权益平衡项目 | 0 | 0 | 0 | -0.01 |
| 股东权益合计 | 5,155,163,607.55 | 5,232,118,902.8 | 5,199,787,286.78 | 5,147,433,038.72 |
| 负债和股东权益合计 | 5,786,870,938.25 | 5,844,995,156.61 | 5,769,310,895.27 | 5,797,002,474.77 |
| 公告日期 | 2025-08-20 | 2025-04-30 | 2025-04-30 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |